Drug class
18F-labelled amino-acid PET radiotracer; diagnostic imaging agent
Mechanism of action
Radiolabelled fluoroethyltyrosine is transported into cells by large neutral amino acid transporters (LAT1/LAT2). Increased uptake in metabolically active tumour tissue can support PET imaging; it is a diagnostic radiopharmaceutical, not a therapeutic tyrosine analogue.
General use cases
- PET imaging of brain tumours in adults with cognitive impairment or suspected glioma to assist assessment of amino-acid transport and tumour activity under the specific radiopharmaceutical product authorisation; the exact intended use is jurisdiction- and product-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
